The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Fluorine (19F) MRS and MRI in biomedicine
Open accessAbstract
Shortly after the introduction of 1 H MRI, fluorinated molecules were tested as MR‐detectable tracers or contrast agents. Many fluorinated compounds, which are nontoxic and chemically inert, are now being used in a broad range of biomedical applications, including anesthetics, chemotherapeutic agents, and molecules with high oxygen solubility for respiration and blood substitution. These compounds can be monitored by fluorine (19 F) MRI and/or MRS, providing a noninvasive means to interrogate associated functions in biological systems. As a result of the lack of endogenous fluorine in living organisms, 19 F MRI of ‘hotspots’ of targeted fluorinated contrast agents has recently opened up new research avenues in molecular and cellular imaging. This includes the specific targeting and imaging of cellular surface epitopes, as well as MRI cell tracking of endogenous macrophages, injected immune cells and stem cell transplants. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
Encyclopedia of nuclear magnetic resonance
(2003) · TrAC Trends in Analytical Chemistry · doi:10.1016/s0165-9936(03)00914-2 · Cited by 1,656
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
Iron oxide MR contrast agents for molecular and cellular imaging
Bulte, J. W. M., & Kraitchman, D. L. (2004) · NMR in Biomedicine · doi:10.1002/nbm.924 · Cited by 1,500
Self-citationO'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,136
A non-disruptive technique for loading calcium buffers and indicators into cells
Tsien, R. Y. (1981) · Nature · doi:10.1038/290527a0 · Cited by 1,131
Encyclopedia of nuclear magnetic resonance
(1997) · Choice Reviews Online · doi:10.5860/choice.34-5424 · Cited by 1,023
Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure
Clark, L. C., & Gollan, F. (1966) · Science · doi:10.1126/science.152.3730.1755 · Cited by 794
In vivo imaging platform for tracking immunotherapeutic cells
Ahrens, E. T., Flores, R., Xu, H., & Morel, P. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1121 · Cited by 620
Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research
Krafft, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00107-7 · Cited by 550
Flacke, S., Fischer, S., Scott, M. J., Fuhrhop, R. J., Allen, J. S., McLean, M., Winter, P., Sicard, G. A., Gaffney, P. J., Wickline, S. A., et al. (2001) · Circulation · doi:10.1161/hc3601.094303 · Cited by 515
19F magnetic resonance imaging
Holland, G. N., Bottomley, P. A., & Hinshaw, W. S. (1977) · Journal of Magnetic Resonance (1969) · doi:10.1016/0022-2364(77)90263-3 · Cited by 491
Self-citationReport of the task group on reference man
Mann, W. B. (1977) · The International Journal of Applied Radiation and Isotopes · doi:10.1016/0020-708x(77)90145-4 · Cited by 433
Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles
Cunningham, C. H., Arai, T., Yang, P. C., McConnell, M. V., Pauly, J. M., & Conolly, S. M. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20477 · Cited by 403
Riess, J. G. (2005) · Artificial Cells, Blood Substitutes, and Biotechnology · doi:10.1081/bio-200046659 · Cited by 361
Flögel, U., Ding, Z., Hardung, H., Jander, S., Reichmann, G., Jacoby, C., Schubert, R., & Schrader, J. (2008) · Circulation · doi:10.1161/circulationaha.107.737890 · Cited by 351
Partlow, K. C., Chen, J., Brant, J. A., Neubauer, A. M., Meyerrose, T. E., Creer, M. H., Nolta, J. A., Caruthers, S. D., Lanza, G. M., & Wicldine, S. A. (2007) · The FASEB Journal · doi:10.1096/fj.06-6505com · Cited by 306
Cohen, J. L., Cheirif, J., Segar, D. S., Gillam, L. D., Gottdiener, J. S., Hausnerova, E., & Bruns, D. E. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00311-8 · Cited by 297
Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI
Morawski, A. M., Winter, P. M., Crowder, K. C., Caruthers, S. D., Fuhrhop, R. W., Scott, M. J., Robertson, J. D., Abendschein, D. R., Lanza, G. M., & Wickline, S. A. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20010 · Cited by 271
Self-delivering Nanoemulsions for Dual Fluorine-19 MRI and Fluorescence Detection
Janjic, J. M., Srinivas, M., Kadayakkara, D. K. K., & Ahrens, E. T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja077388j · Cited by 260
Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes model
Srinivas, M., Morel, P. A., Ernst, L. A., Laidlaw, D. H., & Ahrens, E. T. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21352 · Cited by 259
19F: A Versatile Reporter for Non-Invasive Physiology and Pharmacology Using Magnetic Resonance
Yu, J.-X., Kodibagkar, V., Cui, W., & Mason, R. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053507342 · Cited by 239
Stuber, M., Gilson, W. D., Schär, M., Kedziorek, D. A., Hofmann, L. V., Shah, S., Vonken, E., Bulte, J. W. M., & Kraitchman, D. L. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21399 · Cited by 215
Self-citationBlood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions.
Spahn, D. R. (1999) · Critical Care · doi:10.1186/cc364 · Cited by 200
Human brain fluoxetine concentrations
(1993) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.5.3.322 · Cited by 200
Fluorine‐containing nanoemulsions for MRI cell tracking
Janjic, J. M., & Ahrens, E. T. (2009) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.35 · Cited by 196
Pisani, E., Tsapis, N., Paris, J., Nicolas, V., Cattel, L., & Fattal, E. (2006) · Langmuir · doi:10.1021/la0601455 · Cited by 175
Pharmacokinetics and Side Effects of Perfluorocarbon-Based Blood Substitutes
Flaim, S. F. (1994) · Artificial Cells, Blood Substitutes, and Biotechnology · doi:10.3109/10731199409138801 · Cited by 174
Kitzman, D. W., Goldman, M. E., Gillam, L. D., Cohen, J. L., Aurigemma, G. P., & Gottdiener, J. S. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01050-x · Cited by 166
A Temperature-Sensitive Liposomal 1H CEST and 19F Contrast Agent for MR Image-Guided Drug Delivery
Langereis, S., Keupp, J., van Velthoven, J. L. J., de Roos, I. H. C., Burdinski, D., Pikkemaat, J. A., & Grüll, H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8087532 · Cited by 166
Association of intratumoral pharmacokinetics of fluorouracil with clinical response
Presant, C. A., Wolf, W., Waluch, V, Wiseman, C., Kennedy, P., Blayney, D., Waluch, V, Wolf, W., Brechner, R. R., Presant, C. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92399-x · Cited by 161
NMR spectroscopy of cells and organisms
Gupta, R. K. (1987) · CRC Press eBooks · Cited by 160
In vivo cytometry of antigen‐specific t cells using 19 F MRI
Srinivas, M., Turner, M. S., Janjic, J. M., Morel, P. A., Laidlaw, D. H., & Ahrens, E. T. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22063 · Cited by 158
In vivo “hot spot” MR imaging of neural stem cells using fluorinated nanoparticles
Ruı́z-Cabello, J., Walczak, P., Kedziorek, D., Chacko, V. P., Schmieder, A. H., Wickline, S. A., Lanza, G. M., & Bulte, J. W. M. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21783 · Cited by 153
Self-citationDardzinski, B. J., & Sotak, C. H. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320112 · Cited by 150
Stegman, L. D., Rehemtulla, A., Beattie, B. J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9821 · Cited by 150
Dual‐Function Probe to Detect Protease Activity for Fluorescence Measurement and 19F MRI
Mizukami, S., Takikawa, R., Sugihara, F., Shirakawa, M., & Kikuchi, K. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806328 · Cited by 142
Hexafluorobenzene: a Sensitive 19F NMR Indicator of Tumor Oxygenation
Mason, R. P., Rodbumrung, W., & Antich, P. P. (1996) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199605)9:3<125::aid-nbm405>3.0.co;2-f · Cited by 137
Hot spot MRI emerges from the background
Bulte, J. W. M. (2005) · Nature Biotechnology · doi:10.1038/nbt0805-945 · Cited by 135
Self-citationPerfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging
Mattrey, R. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.2.247 · Cited by 126
Khattak, S. F., Chin, K., Bhatia, S. R., & Roberts, S. C. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21151 · Cited by 123
Gilliland, F. D., & Mandel, J. S. (1996) · American Journal of Industrial Medicine · doi:10.1002/(sici)1097-0274(199605)29:5<560::aid-ajim17>3.0.co;2-z · Cited by 120
Measuring Changes in Tumor Oxygenation
Zhao, D., Jiang, L., & Mason, R. P. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)86018-x · Cited by 112
Caruthers, S. D., Neubauer, A. M., Hockett, F. D., Lamerichs, R. M. J. N., Winter, P. M., Scott, M. J., Gaffney, P. J., Wickline, S. A., & Lanza, G. M. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000199281.60135.6a · Cited by 101
Free cytosolic Ca2+ measurements with fluorine labelled indicators using 19FNMR
Metcalfe, J. C., Hesketh, T. R., & Smith, G. A. (1985) · Cell Calcium · doi:10.1016/0143-4160(85)90043-0 · Cited by 100
Noveck, R. J., Shannon, E., Leese, P. T., Shorr, J. S., Flaim, K. E., Keipert, P. E., & Woods, C. M. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200010000-00009 · Cited by 98
Engineering Blood: Synthetic Substitutes from Fluorinated Compounds
Lowe, K. C. (2003) · Tissue Engineering · doi:10.1089/107632703322066570 · Cited by 92
Imaging obstructed ventilation with NMR using inert fluorinated gases
Kuethe, D. O., Caprihan, A., Gach, H. M., Lowe, I. J., & Fukushima, E. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2279 · Cited by 91
Henry, M., Schmidt, M. E., Hennen, J. A., Villafuerte, R. A., Butman, M. L., Tran, P., Kerner, L. T., Cohen, B. M., & Renshaw, P. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300749 · Cited by 86
Overview of Progress in the Fluorocarbon Approach toin vivoOxygen Delivery
Riess, J. G. (1992) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.3109/10731199209119635 · Cited by 74
Leese, P. T., Noveck, R. J., Shorr, J. S., Woods, C. M., Flaim, K. E., & Keipert, P. E. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200010000-00008 · Cited by 71
Volatile anesthetics compete for common binding sites on bovine serum albumin: a 19F-NMR study.
Dubois, B. W., Cherian, S. F., & Evers, A. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6478 · Cited by 66
Pharmacokinetics using fluorine NMR in vivo
Bachert, P. (1998) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/s0079-6565(98)00016-8 · Cited by 63
Henry, M. E., Moore, C. M., Kaufman, M. J., Michelson, D., Schmidt, M. E., Stoddard, E., Vuckevic, A. J., Berreira, P. J., Cohen, B. M., & Renshaw, P. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1506 · Cited by 61
Schlemmer, H., Becker, M., Bachert, P., Dietz, A., Rudat, V., Vanselow, B., Wollensack, P., ZUNA, I., Knopp, M. V., Weidauer, H., et al. (1999) · PubMed · Cited by 61
Clark, L. C., Ackerman, J. L., Thomas, S. R., Millard, R. W., Hoffman, R. E., Pratt, R. G., Ragle-Cole, H., Kinsey, R. A., & Janakiraman, R. (1984) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-4895-5_81 · Cited by 61
Southworth, R., Parry, C. R., Parkes, H. G., Medina, R. A., & Garlick, P. B. (2003) · NMR in Biomedicine · doi:10.1002/nbm.856 · Cited by 56
Laukemper‐Ostendorf, S., Scholz, A., Bürger, K., Heußel, C. P., Schmittner, M. D., Weiler, N., Markstaller, K., Eberle, B., Kauczor, H., Quintel, M., et al. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10008 · Cited by 52
Strauss, W. L., Layton, M. E., Hayes, C. E., & Dager, S. R. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.516 · Cited by 50
Solomon, B., Binns, D., Roselt, P. D., Weibe, L. I., McArthur, G. A., Cullinane, C. M., & Hicks, R. J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0066 · Cited by 50
Strauss, W. L., Unis, A. S., Cowan, C. A., Dawson, G., & Dager, S. R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.755 · Cited by 43
van Laarhoven, H. W. M., Klomp, D. W. J., Kamm, Y. J. L., Punt, C. J. A., & Heerschap, A. (2003) · PubMed · Cited by 36
MR Three-Dimensional Molecular Imaging of Intramural Biomarkers with Targeted Nanoparticles
Cyrus, T., Abendschein, D. R., Caruthers, S. D., Harris, T. R., Glattauer, V., Werkmeister, J. A., Ramshaw, J. A. M., Wickline, S. A., & Lanza, G. M. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600580296 · Cited by 36
Rafikova, O., Sokolova, E., Rafikov, R., & Nudler, E. (2004) · Circulation · doi:10.1161/01.cir.0000148782.37563.f8 · Cited by 34
In vivo fluorine‐19 MR imaging: Relaxation enhancement with Gd‐DTPA
Lee, H., Price, R. R., Holburn, G. E., Partain, C. L., Adams, M. D., & Cacheris, W. P. (1994) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880040416 · Cited by 30
Miner, C. M., Davidson, J. R. T., Potts, N. L. S., Tupler, L. A., Charles, H. C., & Krishnan, K. R. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00287-1 · Cited by 25
Rotta, A. T., Gunnarsson, B., Fuhrman, B. P., Wiryawan, B., Hernan, L. J., & Steinhorn, D. M. (2003) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000059729.21375.d0 · Cited by 20
Parameter optimization and calibration of 19F magnetic resonance imaging at 1.5 Tesla
Gong, B., Gill, M., Washburn, D. B., Davenport, W. C., Adams, D., & Kwock, L. (1991) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(91)90103-s · Cited by 13
Pfannkuch, F., & Schnoy, N. (1979) · PubMed · Cited by 8
Avian influenza and pandemic influenza threat.
Salzberger, B., & Ruf, B. (2006) · PubMed · Cited by 5
Ojugo (1999) · doi:10.1002/(sici)1099-1492(199912)12:8
Cited by
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects
Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. (2020) · Nanomaterials · doi:10.3390/nano10071403 · Cited by 1,061
Ren, J. M., McKenzie, T. G., Fu, Q., Wong, E. H. H., Xu, J., An, Z., Shanmugam, S., Davis, T. P., Boyer, C., & Qiao, G. G. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00008 · Cited by 839
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
Pros and cons of ultra-high-field MRI/MRS for human application
Ladd, M. E., Bachert, P., Meyerspeer, M., Moser, E., Nagel, A. M., Norris, D. G., Schmitter, S., Speck, O., Straub, S., & Zaiss, M. (2018) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2018.06.001 · Cited by 544
Metadata
- Authors
- Ruiz‐Cabello, J., Barnett, B. P., Bottomley, P. A., & Bulte, J. W. M.
- Venue
- NMR in Biomedicine
- Publisher
- Wiley
- Published
- 2010-09-15
- Volume
- 24
- Issue
- 2
- Pages
- 114-129
- ISSN
- 0952-3480 (ISSN-L)
- 1099-1492
- OpenAlex
- W2166921498
- Cited by
- 489
- References
- 73
- FWCI
- 15.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.